Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1994-07-11
1996-10-15
Chan, Christina Y.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435 7021, 4351722, 5303877, 5303888, 53038885, C12N 520, C07K 1630
Patent
active
055653561
ABSTRACT:
Monoclonal antibody 100-310 is found to be reactive against colon cancer cells and would therefore be useful for diagnostic imaging and treatment of colon cancer.
REFERENCES:
Waldmann Science 252:1657-1622 (1991).
Dillman Annals Internal Medicine 111:592-603 (1989).
Stefel et al. Yalf J Biol Med 57(1984) (Citation Only).
Riker et al. Proc Am Assoc Cancer Res. Ann. Meeting 31(1990).
Welt, et al., J. Clinical Oncology, vol. 8, pp. 1894-1906 (Nov. 1990).
Barendswaard Elsje C.
Divgi Chaitanya R.
Garin-Chesa Pilar
Old Lloyd J.
Welt Sydney
Chan Christina Y.
Gambel Phillip
Memorial Sloan-Kettering Cancer Center
LandOfFree
Hybridoma cell lines which produce monoclonal antibodies having does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridoma cell lines which produce monoclonal antibodies having , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma cell lines which produce monoclonal antibodies having will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1245365